These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17544649)

  • 41. Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go.
    Amato MP
    Neuropediatrics; 2012 Aug; 43(4):174-5. PubMed ID: 22911479
    [No Abstract]   [Full Text] [Related]  

  • 42. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MS and cognition and APOE: the ongoing conundrum about biomarkers.
    Sadovnick AD; Jacobs DH
    Neurology; 2008 Jan; 70(3):164-5. PubMed ID: 18195261
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
    O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
    Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study.
    Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J
    Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of recruitment and participation bias in neuropsychological research among MS patients.
    Duquin JA; Parmenter BA; Benedict RH
    J Int Neuropsychol Soc; 2008 May; 14(3):494-8. PubMed ID: 18419848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A symbol digit modalities test version suitable for functional MRI studies.
    Forn C; Belloch V; Bustamante JC; Garbin G; Parcet-Ibars MA; Sanjuan A; Ventura N; Avila C
    Neurosci Lett; 2009 May; 456(1):11-4. PubMed ID: 19429124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychology of aging and dementia.
    Salmon DP
    Handb Clin Neurol; 2008; 88():113-35. PubMed ID: 18631688
    [No Abstract]   [Full Text] [Related]  

  • 49. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for deficits in facial affect recognition and theory of mind in multiple sclerosis.
    Henry JD; Phillips LH; Beatty WW; McDonald S; Longley WA; Joscelyne A; Rendell PG
    J Int Neuropsychol Soc; 2009 Mar; 15(2):277-85. PubMed ID: 19203428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    Harel Y; Appleboim N; Lavie M; Achiron A
    J Neurol Sci; 2009 Jan; 276(1-2):38-40. PubMed ID: 18817930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.
    Cohen BA
    Neurology; 2008 Dec; 71(24 Suppl 3):S14-20. PubMed ID: 19064870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A longitudinal analysis of cognitive dysfunction, coping, and depression in multiple sclerosis.
    Rabinowitz AR; Arnett PA
    Neuropsychology; 2009 Sep; 23(5):581-91. PubMed ID: 19702412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct mechanisms of altered brain activation in patients with multiple sclerosis.
    Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
    Neuroimage; 2007 Sep; 37(3):937-46. PubMed ID: 17627848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Training is required for users of a screening tests].
    Milchert SM
    Lakartidningen; 2001 Jul; 98(30-31):3359. PubMed ID: 11521348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.